Results 21 to 30 of about 3,069,601 (247)
Dynamic Change in p63 Protein Expression during Implantation of Urothelial Cancer Clusters
Although the dissemination of urothelial cancer cells is supposed to be a major cause of the multicentricity of urothelial tumors, the mechanism of implantation has not been well investigated.
Takahiro Yoshida +7 more
doaj +1 more source
Introduction In Lynch syndrome, urothelial cancer is the third most common cancer, following colorectal and endometrial cancers. Little is known, however, about the efficacy of immune checkpoint inhibitors in the treatment of metastatic urothelial cancer
Ryosuke Oki +7 more
doaj +1 more source
Second line therapy for metastatic urothelial carcinoma. Clinical case of vinflunine use
Urothelial cancer occupies a significant place in the routine practice of cancer treatment. Systemic antitumor treatment of patients with metastatic urothelial cancer in the first line is currently well studied, has its own standards, implemented in ...
A. A. Gritskevich +9 more
doaj +1 more source
[Molecular tumor board-urothelial cancer]. [PDF]
BACKGROUND Molecular tumor boards (MTB) are becoming more common. There are several molecular alterations in urothelial cancer a molecular tumor board can potentially rely on.
Seiler, Roland, Gakis, G, Hupe, M C
core +1 more source
Prognostic and Diagnostic Significance of Platelet Indices in Patients with Urothelial Carcinoma
Some prognostic markers have been shown to determine the course and survival of Urothelial Cancer. A cross-sectional retrospective study, specifically looking at the role that various indices related to platelets—namely Mean Platelet Volume (MPV ...
Gulshan Kumar Mukhiya +3 more
doaj +1 more source
Complete response to FOLFOX4 therapy in a patient with advanced urothelial cancer: a case report
No standard has been established for salvage therapy in gemcitabine refractory advanced urothelial cancer. We report the complete response to FOLFOX4 therapy of a metastatic urothelial cancer patient, for whom adjuvant gemcitabine plus cisplatin ...
Koh Eun +6 more
doaj +1 more source
Bladder cancer is the most common cancer of the urinary system. Bladder urothelial cancer accounts for 90% of bladder cancer. These two cancers have high morbidity and mortality rates worldwide.
Qiongli Su +3 more
doaj +1 more source
Microarray analysis of pathways involved in bladder cancer invasion and metastasis. [PDF]
MDHypoxia-inducible genes have been linked to the aggressive phenotype of cancer. However, nearly all work on hypoxia-regulated genes has been conducted in vitro on cell lines.
Ord, Jonathan J
core +4 more sources
Despite being among the ten most common cancers with high recurrence rates worldwide, there have been no major breakthroughs in the standard treatment options for bladder cancer in recent years.
Aleksandar Janev +10 more
doaj +1 more source
Introduction: There are many established environmental toxins that correlate with urothelial cancer. Genetic variations in phosphoinositide-3 kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway have also been reported to have association with ...
Hao Lun Luo +3 more
doaj +1 more source

